Oui, il existe un risque de récidive, surtout si le traitement est incomplet.
RécidiveTraitementGranulome éosinophile
#3
Y a-t-il des risques de cancer associés ?
Le granulome éosinophile est généralement bénin, mais un suivi est recommandé pour exclure le cancer.
CancerSuiviGranulome éosinophile
#4
Les complications affectent-elles la qualité de vie ?
Oui, les douleurs et les déformations peuvent affecter la qualité de vie des patients.
Qualité de vieDouleursComplications
#5
Comment gérer les complications ?
La gestion des complications peut inclure des traitements symptomatiques et un suivi régulier.
GestionComplicationsTraitements symptomatiques
Facteurs de risque
5
#1
Quels sont les facteurs de risque du granulome éosinophile ?
Les facteurs incluent des antécédents d'allergies, d'asthme et d'exposition à des irritants.
Facteurs de risqueAllergiesAsthme
#2
L'âge influence-t-il le risque ?
Oui, le granulome éosinophile est plus fréquent chez les jeunes enfants et les adolescents.
ÂgeEnfantsGranulome éosinophile
#3
Le sexe joue-t-il un rôle dans le risque ?
Oui, il existe une légère prédominance chez les hommes par rapport aux femmes.
SexePrédominanceGranulome éosinophile
#4
Les maladies auto-immunes augmentent-elles le risque ?
Oui, certaines maladies auto-immunes peuvent augmenter le risque de granulome éosinophile.
Maladies auto-immunesRisqueGranulome éosinophile
#5
L'exposition professionnelle à des irritants est-elle un facteur ?
Oui, l'exposition à des produits chimiques ou à des irritants peut augmenter le risque.
Exposition professionnelleIrritantsRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Granulome éosinophile : Questions médicales les plus fréquentes",
"headline": "Granulome éosinophile : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Granulome éosinophile : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-14",
"dateModified": "2025-04-10",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Granulome éosinophile"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Granulome",
"url": "https://questionsmedicales.fr/mesh/D006099",
"about": {
"@type": "MedicalCondition",
"name": "Granulome",
"code": {
"@type": "MedicalCode",
"code": "D006099",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C23.550.382"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Granulome éosinophile",
"alternateName": "Eosinophilic Granuloma",
"code": {
"@type": "MedicalCode",
"code": "D004803",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Marc E Rothenberg",
"url": "https://questionsmedicales.fr/author/Marc%20E%20Rothenberg",
"affiliation": {
"@type": "Organization",
"name": "From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD."
}
},
{
"@type": "Person",
"name": "Yiming Zheng",
"url": "https://questionsmedicales.fr/author/Yiming%20Zheng",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Orthopaedics, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Dahui Wang",
"url": "https://questionsmedicales.fr/author/Dahui%20Wang",
"affiliation": {
"@type": "Organization",
"name": "Department of Paediatric Orthopaedics, Children's Hospital of Fudan University, National Children's Medical Center, Shanghai, China."
}
},
{
"@type": "Person",
"name": "Albert J Bredenoord",
"url": "https://questionsmedicales.fr/author/Albert%20J%20Bredenoord",
"affiliation": {
"@type": "Organization",
"name": "From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD."
}
},
{
"@type": "Person",
"name": "David J Jackson",
"url": "https://questionsmedicales.fr/author/David%20J%20Jackson",
"affiliation": {
"@type": "Organization",
"name": "Guy's Severe Asthma Centre, Guy's & St Thomas' NHS Trust, London, UK david.jackson@gstt.nhs.uk."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Acquired butterfly vertebra as a sequela of eosinophilic granuloma.",
"datePublished": "2022-12-15",
"url": "https://questionsmedicales.fr/article/36520219",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00256-022-04249-5"
}
},
{
"@type": "ScholarlyArticle",
"name": "Eosinophilic granuloma of the calvarium: is conservative management a valid option? Illustrative case and systematic review of the literature.",
"datePublished": "2023-03-20",
"url": "https://questionsmedicales.fr/article/36939904",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s00381-023-05926-z"
}
},
{
"@type": "ScholarlyArticle",
"name": "Some aspects of the diagnosis and treatment of eosinophilic granuloma in cats.",
"datePublished": "2023-12-19",
"url": "https://questionsmedicales.fr/article/38130457",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.2478/jvetres-2023-0060"
}
},
{
"@type": "ScholarlyArticle",
"name": "Rare clival localization of an eosinophilic granuloma: illustrative case.",
"datePublished": "2023-06-19",
"url": "https://questionsmedicales.fr/article/37354435",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3171/CASE22490"
}
},
{
"@type": "ScholarlyArticle",
"name": "Schistosomiasis Mansoni-Recruited Eosinophils: An Overview in the Granuloma Context.",
"datePublished": "2022-10-13",
"url": "https://questionsmedicales.fr/article/36296298",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/microorganisms10102022"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "États, signes et symptômes pathologiques",
"item": "https://questionsmedicales.fr/mesh/D013568"
},
{
"@type": "ListItem",
"position": 3,
"name": "Processus pathologiques",
"item": "https://questionsmedicales.fr/mesh/D010335"
},
{
"@type": "ListItem",
"position": 4,
"name": "Granulome",
"item": "https://questionsmedicales.fr/mesh/D006099"
},
{
"@type": "ListItem",
"position": 5,
"name": "Granulome éosinophile",
"item": "https://questionsmedicales.fr/mesh/D004803"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Granulome éosinophile - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Granulome éosinophile",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-17",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Granulome éosinophile",
"description": "Comment diagnostique-t-on un granulome éosinophile ?\nQuels tests sont utilisés pour confirmer le diagnostic ?\nLes radiographies sont-elles utiles dans le diagnostic ?\nLe diagnostic différentiel est-il nécessaire ?\nQuels signes cliniques aident au diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D004803#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Granulome éosinophile",
"description": "Quels sont les symptômes courants du granulome éosinophile ?\nLe granulome éosinophile cause-t-il des démangeaisons ?\nPeut-on avoir des symptômes respiratoires ?\nLes symptômes varient-ils selon l'âge ?\nY a-t-il des symptômes systémiques associés ?",
"url": "https://questionsmedicales.fr/mesh/D004803#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Granulome éosinophile",
"description": "Peut-on prévenir le granulome éosinophile ?\nLes allergies jouent-elles un rôle dans la prévention ?\nY a-t-il des mesures d'hygiène à suivre ?\nLes vaccinations sont-elles utiles ?\nLe suivi médical régulier est-il important ?",
"url": "https://questionsmedicales.fr/mesh/D004803#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Granulome éosinophile",
"description": "Quels traitements sont disponibles pour le granulome éosinophile ?\nLes corticostéroïdes sont-ils efficaces ?\nLa chirurgie est-elle nécessaire dans tous les cas ?\nY a-t-il des traitements alternatifs ?\nLa surveillance active est-elle une option ?",
"url": "https://questionsmedicales.fr/mesh/D004803#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Granulome éosinophile",
"description": "Quelles complications peuvent survenir ?\nLe granulome éosinophile peut-il récidiver ?\nY a-t-il des risques de cancer associés ?\nLes complications affectent-elles la qualité de vie ?\nComment gérer les complications ?",
"url": "https://questionsmedicales.fr/mesh/D004803#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Granulome éosinophile",
"description": "Quels sont les facteurs de risque du granulome éosinophile ?\nL'âge influence-t-il le risque ?\nLe sexe joue-t-il un rôle dans le risque ?\nLes maladies auto-immunes augmentent-elles le risque ?\nL'exposition professionnelle à des irritants est-elle un facteur ?",
"url": "https://questionsmedicales.fr/mesh/D004803#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on un granulome éosinophile ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur l'examen clinique, l'imagerie et la biopsie tissulaire."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer le diagnostic ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins et une biopsie peuvent être effectués pour confirmer la présence d'éosinophiles."
}
},
{
"@type": "Question",
"name": "Les radiographies sont-elles utiles dans le diagnostic ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les radiographies peuvent montrer des lésions osseuses caractéristiques du granulome éosinophile."
}
},
{
"@type": "Question",
"name": "Le diagnostic différentiel est-il nécessaire ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il est important d'exclure d'autres conditions comme les infections ou les tumeurs."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques aident au diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des douleurs osseuses, des lésions cutanées ou des symptômes respiratoires peuvent indiquer la maladie."
}
},
{
"@type": "Question",
"name": "Quels sont les symptômes courants du granulome éosinophile ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les symptômes incluent des douleurs, des gonflements et des lésions cutanées."
}
},
{
"@type": "Question",
"name": "Le granulome éosinophile cause-t-il des démangeaisons ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines lésions cutanées peuvent provoquer des démangeaisons."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes respiratoires ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des symptômes respiratoires peuvent survenir si les poumons sont affectés."
}
},
{
"@type": "Question",
"name": "Les symptômes varient-ils selon l'âge ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent varier en fonction de l'âge et de la localisation des lésions."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes systémiques associés ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes systémiques comme la fièvre ou la fatigue peuvent parfois être présents."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir le granulome éosinophile ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de méthode de prévention spécifique, mais éviter les allergènes peut aider."
}
},
{
"@type": "Question",
"name": "Les allergies jouent-elles un rôle dans la prévention ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la gestion des allergies peut réduire le risque de développer des granulomes éosinophiles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des mesures d'hygiène à suivre ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Maintenir une bonne hygiène peut aider à réduire le risque d'infections associées."
}
},
{
"@type": "Question",
"name": "Les vaccinations sont-elles utiles ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccinations peuvent prévenir certaines infections, mais ne ciblent pas spécifiquement le granulome."
}
},
{
"@type": "Question",
"name": "Le suivi médical régulier est-il important ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un suivi médical peut aider à détecter précocement les complications potentielles."
}
},
{
"@type": "Question",
"name": "Quels traitements sont disponibles pour le granulome éosinophile ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les traitements incluent des corticostéroïdes, la chirurgie ou la surveillance active."
}
},
{
"@type": "Question",
"name": "Les corticostéroïdes sont-ils efficaces ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les corticostéroïdes peuvent réduire l'inflammation et la taille des granulomes."
}
},
{
"@type": "Question",
"name": "La chirurgie est-elle nécessaire dans tous les cas ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, la chirurgie est réservée aux cas graves ou lorsque les symptômes persistent."
}
},
{
"@type": "Question",
"name": "Y a-t-il des traitements alternatifs ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des traitements alternatifs comme l'immunothérapie peuvent être envisagés dans certains cas."
}
},
{
"@type": "Question",
"name": "La surveillance active est-elle une option ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, dans les cas asymptomatiques, une surveillance régulière peut être suffisante."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent des infections secondaires et des déformations osseuses."
}
},
{
"@type": "Question",
"name": "Le granulome éosinophile peut-il récidiver ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe un risque de récidive, surtout si le traitement est incomplet."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de cancer associés ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le granulome éosinophile est généralement bénin, mais un suivi est recommandé pour exclure le cancer."
}
},
{
"@type": "Question",
"name": "Les complications affectent-elles la qualité de vie ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les douleurs et les déformations peuvent affecter la qualité de vie des patients."
}
},
{
"@type": "Question",
"name": "Comment gérer les complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "La gestion des complications peut inclure des traitements symptomatiques et un suivi régulier."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque du granulome éosinophile ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des antécédents d'allergies, d'asthme et d'exposition à des irritants."
}
},
{
"@type": "Question",
"name": "L'âge influence-t-il le risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le granulome éosinophile est plus fréquent chez les jeunes enfants et les adolescents."
}
},
{
"@type": "Question",
"name": "Le sexe joue-t-il un rôle dans le risque ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, il existe une légère prédominance chez les hommes par rapport aux femmes."
}
},
{
"@type": "Question",
"name": "Les maladies auto-immunes augmentent-elles le risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies auto-immunes peuvent augmenter le risque de granulome éosinophile."
}
},
{
"@type": "Question",
"name": "L'exposition professionnelle à des irritants est-elle un facteur ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'exposition à des produits chimiques ou à des irritants peut augmenter le risque."
}
}
]
}
]
}
From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD.
From the Divisions of Allergy and Immunology (M.E.R., J.M.C.) and Pathology and Laboratory Medicine (M.H.C.), Department of Pediatrics, and the Department of Pathology and Laboratory Medicine (M.H.C.), University of Cincinnati College of Medicine, Cincinnati Children's Hospital Medical Center, Cincinnati; the Center for Esophageal Diseases and Swallowing, Division of Gastroenterology and Hepatology, University of North Carolina at Chapel Hill School of Medicine, Chapel Hill (E.S.D.); the Department of Gastroenterology and Hepatology, Amsterdam University Medical Centers, Amsterdam (A.J.B.); the Kenneth C. Griffin Esophageal Center, Division of Gastroenterology and Hepatology, Northwestern University Feinberg School of Medicine, Chicago (I.H.); the Division of Gastroenterology, Department of Internal Medicine, University of Utah, Salt Lake City (K.A.P.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Cambridge, United Kingdom (L.B.); Late-Stage Respiratory and Immunology, BioPharmaceuticals Research and Development, AstraZeneca, Gothenburg, Sweden (H.F., H.G.); and Patient Centered Science, BioPharmaceuticals Medical Evidence (C.N.H.), Late-stage Respiratory and Immunology (M.K., C.J.D.) and Translational Science and Experimental Medicine, Early Respiratory and Immunology (C.M.), BioPharmaceuticals Research and Development, and Data Sciences and AI (D.S.) and Clinical Pharmacology and Quantitative Pharmacology, Clinical Pharmacology and Safety Sciences (W.I.W.), Research and Development, AstraZeneca, Gaithersburg, MD.
Butterfly vertebras are an abnormal embryological formation of the spinal bodies that occur because of a lack of fusion of the chondrification centers of the vertebral bodies. Langerhans cell histiocy...
Eosinophilic granuloma (EG) is the most common form of Langerhans cell histiocytosis, presenting as a single osteolytic lesion of the calvarium. Its diagnosis is based on typical clinical and radiolog...
Methods. Here, we report a case of EG with typical clinical and radiological features which, due to intervening circumstances, was resected in a delayed fashion. Moreover, we perform a systematic revi...
In our case, histological examination showed ongoing bone regeneration with no traces of the disease. Through our literature review, we found 47 cases of calvarial EG managed with watchful waiting. No...
Our report provides further evidence that watchful waiting can be a reasonable option in the management of single calvarial EG....
Eosinophils represent the most active cells in mammals that show protective and assistive activity in the host immune defence against helminth parasites. These cells are also responsible for the reduc...
The study was carried out on 30 cats with inflammatory skin lesions. The cats ranged in age from seven months to 13 years, and had an average age of three years. The research methodology included info...
In total, 30 cats were diagnosed with eosinophilic granuloma complex. The distribution of lesions was 87.1% in the skin and 12.9% at the skin-mucosal junction. The lesions increased and decreased with...
Eosinophilic granuloma complex in cats is a serious pathology and frequently requires lifelong treatment, so it is important to diagnose it quickly and accurately to ensure optimal treatment of affect...
Eosinophilic granuloma (EG) belongs to the family of Langerhans cell histiocytosis (LCH) and is considered to be a benign disease typically found in children younger than 15 years of age. Here, the au...
The authors report a 9-year-old girl with an EG presenting as an osteolytic lesion of the clivus. After transsphenoidal resection and histological confirmation, adjuvant chemotherapy was initiated. Pr...
Although these lesions are rare, one should consider EG as a differential diagnosis when confronted with osteolytic lesions of the clivus....
Eosinophils are remarkably recruited during schistosomiasis mansoni, one of the most common parasitic diseases worldwide. These cells actively migrate and accumulate at sites of granulomatous inflamma...
To investigate the efficacy and safety of low-dose radiotherapy in treating eosinophilic lymphoid granuloma....
This study included a total of 20 patients diagnosed with eosinophilic lymphoid granuloma. All patients underwent low-dose three-dimensional conformal intensity-modulated radiotherapy for their lesion...
The overall effectiveness of low-dose radiotherapy in treating eosinophilic lymphoid granuloma was 90%. The incidence of grade I and grade II adverse reactions induced by radiotherapy was 70% and 30%,...
Low-dose radiotherapy demonstrates an apparent therapeutic effect on eosinophilic lymphoid granuloma with acceptable adverse reactions....
Spinal eosinophilic granulomas (EG) are rare tumors, mostly reported in the pediatric age group. They constitute <1% of primary bone neoplasms, and cervical spine involvement is uncommon....
A 20-year-old male presented with neck pain for a 4-month duration. Six years previously, he had received six cycles of vinblastine for biopsy-proven histiocytosis of an axillary lymph node; this resu...
Cervical spine EG is rare in adults. CT-guided biopsy should confirm the diagnosis and should be followed by definitive surgery and adjuvant radiotherapy....
Eosinophilic granuloma (EG) is a rare benign tumor-like disorder characterized by abnormal proliferation Langerhans cells. EG frequently presents as a solitary lesion in the axial skeleton and diaphys...
The rare form and mildest variant of Langerhans cell histiocytosis is eosinophilic granuloma (EG). In the clinical presentation, EG can be monostotic, polyostotic, or can encompass many organs. The pa...
An 8-year-old girl presented with a 4 months history of a right parietal bone swelling of the skull with an offensive odor. There was no discharge and no history of vomiting or trauma. An MRI scan of ...
EG has a variety of presentations and should be suspected when tenderness and local swelling are present. Radiography was found to be helpful in the diagnosis and surgical treatment was done to manage...
A 46-year-old man who had been diagnosed with eosinophilic otitis media (EOM) and eosinophilic chronic rhinosinusitis was referred to our department. He suffered from bilateral earache, clogged ear se...